Bioharvest Sciences Inc (BHST) Stock Price, Quote & News

Company Profile

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional...

Industry: Packaged Foods

Sector: Consumer Defensive

Phone: 604 689 5722

Fax: 604 685 9182

Website: www.bioharvest.com

Address:

1140-625 Howe Street, Vancouver, Canada

Stock_Catcher Sep. 4 at 11:52 AM

$BHST BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

0 · Reply

BioHarvest_Sciences Sep. 3 at 3:59 PM

$BHST News Release--> BioHarvest Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE). The dual listing would make Common shares available on both Nasdaq and TASE under the symbol "BHST", with TASE trading expected to begin on September 8, 2026. Read full news release: https://ir.bioharvest.com/

0 · Reply

newsfile_corp Sep. 3 at 11:01 AM

https://nfne.ws/312769 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

MikiTrader Aug. 28 at 2:03 PM

$BHST For now, I'm just gonna sit back and observe a little.

0 · Reply

sepsis74 Aug. 27 at 2:44 PM

$BHST Ilan the former CEO seems to be totally out of the picture now. Not one mention in that Investor Summit yesterday.

0 · Reply

mankind1 Aug. 26 at 10:16 PM

$BHST I still think this has potential

0 · Reply

BioHarvest_Sciences Aug. 12 at 2:50 PM

$BHST Live Webcast today @1pm ET from 46th Annual Canaccord Growth Conference. Watch CEO Zaki Rakib present following the August 11 2026 CDMO Manufacturing and Supply announcement and the sharing of Q2 2026 Financials. Webcast link: https://t.co/yLNTgZQQ87

0 · Reply

EarningsInsider Aug. 11 at 1:00 PM

https://www.marketbeat.com/earnings/reports/2026-8-10-bioharvest-sciences-inc-stock/ $BHST BioHarvest Sciences Earnings Transcript

0 · Reply

BioHarvest_Sciences Aug. 11 at 11:22 AM

$BHST News Release--> BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance Exclusive agreement through 2027 and 2028 is estimated to generate $20-$30 million in revenue and positions BioHarvest in sustainable rare luxury fragrance manufacturing . Read Full news release: https://bit.ly/45PSa3k

0 · Reply

StocktwitsEarnings Aug. 11 at 11:07 AM

$BHST Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.17 up 29.17% YoY • Reported revenue of $8.84M up 3.78% YoY • BioHarvest Sciences Inc. expects the CDMO business to generate $4-$5 million in revenue, while consolidated EBITDA losses are expected to be in the range of $3 million to $5 million.

0 · Reply

BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

Aug 26, 2026, 9:00 AM EDT - 12 days ago

BioHarvest Sciences Transcript: Q3 Investor Summit Group Virtual Conference 2026

2026-08-17T15:10:31.000Z - 21 days ago

BioHarvest Sciences management to meet virtually with Craig-Hallum

2026-08-17T09:46:25.000Z - 21 days ago

BioHarvest Sciences price target lowered to $8 from $10 at Roth Capital

2026-08-17T09:36:39.000Z - 21 days ago

BioHarvest Sciences price target lowered to $5 from $12 at Maxim

Aug 12, 2026, 1:00 PM EDT - 26 days ago

BioHarvest Sciences Transcript: Canaccord Genuity's 46th Annual Growth Conference

Aug 11, 2026, 8:00 AM EDT - 27 days ago

BioHarvest Sciences Earnings Call Transcript: Q2 2026

Aug 11, 2026, 8:00 AM EDT - 27 days ago

BioHarvest Sciences Earnings release: Q2 2026

Aug 11, 2026, 7:00 AM EDT - 27 days ago

BioHarvest Sciences Slides: Corporate presentation

Aug 11, 2026, 6:30 AM EDT - 27 days ago

BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 11, 2026, 6:00 AM EDT - 27 days ago

BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance

Jul 29, 2026, 8:00 AM EDT - 5 weeks ago

BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference

Jul 28, 2026, 8:00 AM EDT - 5 weeks ago

BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026

Jul 15, 2026, 7:30 AM EDT - 7 weeks ago

BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis

Jul 13, 2026, 8:00 AM EDT - 1 month ago

BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC

Jun 18, 2026, 7:30 AM EDT - 2 months ago

BioHarvest Sciences to Present at the 2026 BIO International Convention

May 18, 2026, 7:00 AM EDT - 3 months ago

Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation

May 14, 2026, 8:00 AM EDT - 3 months ago

BioHarvest Sciences Earnings Call Transcript: Q1 2026

May 14, 2026, 8:00 AM EDT - 3 months ago

BioHarvest Sciences Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026, 5:32 PM EDT - 3 months ago

BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division

May 13, 2026, 8:00 AM EDT - 3 months ago

BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications

May 12, 2026, 7:30 AM EDT - 3 months ago

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

May 1, 2026, 7:00 AM EDT - 4 months ago

BioHarvest Sciences Slides: Corporate presentation

Apr 30, 2026, 4:05 PM EDT - 4 months ago

BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026

Apr 29, 2026, 8:30 AM EDT - 4 months ago

BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy

Apr 1, 2026, 7:00 AM EDT - 5 months ago

BioHarvest Sciences Slides: Corporate presentation

Mar 31, 2026, 4:30 PM EDT - 5 months ago

BioHarvest Sciences Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 5 months ago

BioHarvest Sciences Earnings release: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 5 months ago

BioHarvest Sciences Annual report: Q4 2025

Mar 31, 2026, 4:02 PM EDT - 5 months ago

BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results

Mar 31, 2026, 8:00 AM EDT - 5 months ago

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform

Mar 26, 2026, 7:30 AM EDT - 5 months ago

BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States

Mar 17, 2026, 8:30 AM EDT - 5 months ago

BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Mar 13, 2026, 4:53 PM EDT - 5 months ago

BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors

Mar 5, 2026, 7:30 AM EST - 6 months ago

BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy

Mar 3, 2026, 8:30 AM EST - 6 months ago

BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026

2026-02-19T09:55:30.000Z - 6 months ago

BioHarvest Sciences initiated with a Buy at Roth Capital

Jan 7, 2026, 7:30 AM EST - 8 months ago

BioHarvest Sciences Issues Year End Shareholder Letter

Dec 18, 2025, 7:30 AM EST - 8 months ago

BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform

Dec 3, 2025, 7:30 AM EST - 9 months ago

BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product

Nov 13, 2025, 4:30 PM EST - 9 months ago

BioHarvest Sciences Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

BioHarvest Sciences Earnings release: Q3 2025

Nov 13, 2025, 4:05 PM EST - 9 months ago

BioHarvest Sciences Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 8:42 AM EST - 9 months ago

BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025

Nov 10, 2025, 4:18 PM EST - 10 months ago

BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares

2025-11-07T12:56:34.000Z - 10 months ago

BioHarvest Sciences 2.485M share Spot Secondary priced at $7.00

Nov 7, 2025, 7:30 AM EST - 10 months ago

BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock

2025-11-06T22:01:29.000Z - 10 months ago

BioHarvest Sciences files common shares offering, no amount given

Nov 6, 2025, 4:37 PM EST - 10 months ago

BioHarvest Announces Proposed Public Offering of Common Stock

Nov 4, 2025, 7:30 AM EST - 10 months ago

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

Oct 30, 2025, 7:30 AM EDT - 10 months ago

BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis

Sep 22, 2025, 6:32 AM EDT - 11 months ago

BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction

Sep 10, 2025, 1:00 PM EDT - 12 months ago

BioHarvest Sciences Transcript: Status Update

Sep 10, 2025, 1:00 PM EDT - 12 months ago

BioHarvest Sciences Press release: Status Update

2025-09-10T13:40:45.000Z - 12 months ago

BioHarvest Sciences Inc. – Common Stock trading resumes

2025-09-10T13:35:33.000Z - 12 months ago

BioHarvest Sciences Inc. – Common Stock trading halted, volatility trading pause

Sep 10, 2025, 7:00 AM EDT - 12 months ago

BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale

Sep 4, 2025, 7:00 AM EDT - 1 year ago

BioHarvest Sciences Slides: Investor Presentation

Sep 2, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET

Aug 28, 2025, 8:00 AM EDT - 1 year ago

BioHarvest Sciences Registration statement: Registration Filing

Aug 12, 2025, 11:00 AM EDT - 1 year ago

BioHarvest Sciences Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 11, 2025, 8:00 AM EDT - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 1 year ago

BioHarvest Sciences Earnings release: Q2 2025

Aug 11, 2025, 7:30 AM EDT - 1 year ago

BioHarvest Sciences Reports Second Quarter 2025 Financial Results

2025-08-06T15:30:16.000Z - 1 year ago

BioHarvest Sciences management to meet with Craig-Hallum

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

Jul 23, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025

Jun 4, 2025, 7:00 AM EDT - 1 year ago

BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles

May 21, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound

May 15, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings release: Q1 2025

May 15, 2025, 4:05 PM EDT - 1 year ago

BioHarvest Sciences Reports First Quarter 2025 Financial Results

May 12, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

2025-05-07T15:40:53.000Z - 1 year ago

BioHarvest Sciences management to meet with Craig-Hallum

2025-05-05T12:31:25.000Z - 1 year ago

Craig-Hallum bullish on BioHarvest Sciences, initiates with a Buy

2025-05-05T11:41:22.000Z - 1 year ago

BioHarvest Sciences initiated with a Buy at Craig-Hallum

May 1, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

2025-04-25T20:25:52.000Z - 1 year ago

BioHarvest Sciences participates in a conference call with Maxim Group

Mar 31, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Earnings release: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

BioHarvest Sciences Annual report: Q4 2024

Mar 31, 2025, 4:05 PM EDT - 1 year ago

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 8:30 AM EDT - 1 year ago

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

Mar 6, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

Mar 4, 2025, 8:30 AM EST - 1 year ago

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

Feb 18, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

Feb 12, 2025, 8:30 AM EST - 1 year ago

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

Jan 22, 2025, 8:30 AM EST - 1 year ago

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Stock_Catcher Sep. 4 at 11:52 AM

$BHST BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

0 · Reply

BioHarvest_Sciences Sep. 3 at 3:59 PM

0 · Reply

newsfile_corp Sep. 3 at 11:01 AM

https://nfne.ws/312769 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

MikiTrader Aug. 28 at 2:03 PM

$BHST For now, I'm just gonna sit back and observe a little.

0 · Reply

sepsis74 Aug. 27 at 2:44 PM

$BHST Ilan the former CEO seems to be totally out of the picture now. Not one mention in that Investor Summit yesterday.

0 · Reply

mankind1 Aug. 26 at 10:16 PM

$BHST I still think this has potential

0 · Reply

BioHarvest_Sciences Aug. 12 at 2:50 PM

0 · Reply

EarningsInsider Aug. 11 at 1:00 PM

https://www.marketbeat.com/earnings/reports/2026-8-10-bioharvest-sciences-inc-stock/ $BHST BioHarvest Sciences Earnings Transcript

0 · Reply

BioHarvest_Sciences Aug. 11 at 11:22 AM

0 · Reply

StocktwitsEarnings Aug. 11 at 11:07 AM

0 · Reply

newsfile_corp Aug. 11 at 10:31 AM

https://nfne.ws/309164 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Earnings #QuarterlyResult

0 · Reply

Javdemav Aug. 11 at 10:21 AM

$BHST

0 · Reply

newsfile_corp Aug. 11 at 10:02 AM

https://nfne.ws/309157 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Agreement #NASDAQ #Invest

0 · Reply

BioHarvest_Sciences Jul. 29 at 6:21 PM

$BHST News Release--> BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference. CEO Zaki Rakib will present at 1pm ET, August 12. Webcast link: https://event.summitcast.com/view/WuFmFdTcA9mVsUGHZJFU62/nfY3m9akBmhvezmVQ8SM7d

0 · Reply

newsfile_corp Jul. 29 at 12:00 PM

https://nfne.ws/307087 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

forgottenchuck Jul. 29 at 7:06 AM

$BHST what the hell happen t6o this stock, is it going bankrupt

0 · Reply

tomjordan1 Jul. 29 at 3:14 AM

$BHST this will be one of those sleepers that makes a big move to $40 one day

1 · Reply

LewisDaKat Jul. 28 at 3:30 PM

$BHST BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026 https://marketwirenews.com/stock/bhst/news/bioharvest-sciences-to-report-second-quarter-2026-fi-6970270563276808.html?utm_source=stocktwits

0 · Reply

newsfile_corp Jul. 28 at 12:01 PM

https://nfne.ws/306896 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Earnings #QuarterlyResult

0 · Reply

newsfile_corp Jul. 15 at 11:30 AM

https://nfne.ws/305238 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

BioHarvest_Sciences Jul. 13 at 2:51 PM

$BHST News Release--> BioHarvest Sciences to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC CEO Zaki Rakib will participate in a fireside chat at the upcoming Maxim Health, Wellness & Longevity Conference, to be held virtually on Wednesday, July 22, 2026, at 10:00 a.m. ET. In this virtual conference, Maxim Group Research Analysts sit down with leaders from companies at the forefront of innovation across beverages, food, supplements, and longevity. Participants will discuss shifting consumer preferences, the science behind emerging ingredients, building trusted brands, navigating regulation, and capturing share in some of the fastest-growing categories in consumer health. The event is limited to Maxim Digital members - to open an account, visit https://lnkd.in/eWYafewK View BioHarvest news release: https://ir.bioharvest.com/news/default.aspx

0 · Reply

newsfile_corp Jul. 13 at 12:01 PM

https://nfne.ws/304919 $BHST @BioHarvestBHSC #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing

0 · Reply

Market Cap	35.70M
Revenue (ttm)	34.51M
Net Income (ttm)	-11.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-32.28%
Debt to Equity Ratio	0.13

Volume	49,800
Avg Vol	59,128
Day's Range	N/A - N/A
Shares Out	19.62M
Stochastic %K	8%
Beta	0.94
Analysts	Strong Sell
Price Target	$10.50